About

Publications While At HealthPartners

selected publications

Journal Article

Glycaemic control and hypoglycaemia during 12 months of randomized treatment with insulin glargine 300 U/mL versus glargine 100 U/mL in people with type 1 diabetes (EDITION 4). 

Diabetes, Obesity & Metabolism. 2018

Glycaemic control and hypoglycaemia with insulin glargine 300U/mL versus insulin glargine 100U/mL in insulin-naive people with type 2 diabetes: 12-month results from the EDITION 3 trial. 

Diabetes and Metabolism. 2017

Efficacy and safety of flexible versus fixed dosing intervals of insulin glargine 300 U/mL in people with type 2 diabetes. 

Diabetes Technology & Therapeutics. 2016

Clinical utility of SMBG: recommendations on the use and reporting of SMBG in clinical research. 

Diabetes care. 2015

New insulin Glargine 300 Units/mL versus Glargine 100 Units/mL in people with type 1 diabetes: a randomized, phase 3a, open-label clinical trial (EDITION 4). 

Diabetes care. 2015

New insulin glargine 300 U/ml compared with glargine 100 U/ml in insulin-naive people with type 2 diabetes on oral glucose-lowering drugs: a randomized controlled trial (EDITION 3). 

Diabetes, Obesity & Metabolism. 2015

Observations on blood lipid and intermediary metabolite concentrations during conventional insulin treatment or CSII. 

Diabetes. 1985

Contact

full name

P. D. Home

Quick Info

 

Collaboration

Co-author network

Map of science